QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
QuidelOrtho Corp
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 7, 2026
$12.76−0.15 (-1.16%)
Close on Oct 19, 2026
- Market cap
- $871.51M
- P/E (TTM)
- –
- Dividend yield
- –
QuidelOrtho statistics
Financials through Jun 28, 2026, price as of Oct 19, 2026, median of In Vitro & In Vivo Diagnostic Substances companies for comparison
Valuation
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Market Cap | $875.02M | $164.85M |
| Enterprise Value | $3.64B | $87.06M |
| PS Ratio | 0.33 | 3.60 |
| PB Ratio | 0.49 | 2.03 |
Enterprise value
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| EV / Sales | 1.36 | 2.43 |
Income (trailing twelve months)
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Revenue | $2.67B | $57.94M |
| Gross Profit | $1.19B | $90.47M |
| Operating Income | -$824.70M | -$21.44M |
| Pretax Income | -$1.03B | -$14.45M |
| Net Income | -$1.05B | -$22.46M |
| EBITDA | -$370.50M | -$16.91M |
| EPS (Diluted) | -$15.41 | -$0.83 |
Margins
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Gross Margin | 44.6% | 52.3% |
| Operating Margin | -30.8% | -44.5% |
| Pretax Margin | -38.5% | -13.0% |
| Profit Margin | -39.2% | -39.2% |
| EBITDA Margin | -13.9% | -31.3% |
| FCF Margin | -7.90% | -8.85% |
Returns
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Return on Equity (ROE) | -45.9% | -53.1% |
| Return on Assets (ROA) | -17.3% | -41.0% |
| Return on Invested Capital (ROIC) | -13.3% | -32.0% |
| Return on Capital Employed (ROCE) | -17.5% | -37.8% |
Growth
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -2.46% | 6.01% |
| FCF Growth (YoY) | -1724.6% | 2.34% |
| Revenue Growth (3Y CAGR) | -5.80% | 2.25% |
| Revenue Growth (5Y CAGR) | 10.4% | 6.42% |
Balance sheet
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $123.40M | $62.42M |
| Total Debt | $2.89B | $120.13M |
| Net Cash (Debt) | -$2.77B | $15.68M |
| Net Cash Per Share | -$40.36 | $0.66 |
| Equity (Book Value) | $1.77B | $48.79M |
| Book Value Per Share | $25.88 | $1.36 |
| Tangible Book Value | -$903.50M | $23.06M |
| Working Capital | $383.20M | $75.77M |
Financial position
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Current Ratio | 1.39 | 3.30 |
| Quick Ratio | 0.48 | 2.39 |
| Debt / Equity | 1.63 | 0.51 |
| Interest Coverage | -4.06 | -7.12 |
Cash flow (trailing twelve months)
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Operating Cash Flow | -$57.20M | -$12.35M |
| Capital Expenditures | -$154.00M | -$1.06M |
| Free Cash Flow | -$211.20M | -$20.28M |
| FCF Per Share | -$3.08 | -$0.42 |
Efficiency
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Asset Turnover | 0.44 | 0.38 |
| Inventory Turnover | 2.47 | 2.67 |
| Revenue Per Employee | $411.42K | $398.96K |
| Profits Per Employee | -$161.29K | -$703.34K |
| Employee Count | 6,500 | 74 |
Dividends and yields
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Earnings Yield | -119.8% | -22.7% |
| FCF Yield | -24.1% | -9.07% |
| Buyback Yield | -0.59% | -0.73% |
| Shareholder Yield | -0.59% | 0.00% |
Shares
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Shares Outstanding | 68,575,400 | 58,179,650 |
| Shares Change (YoY) | 0.96% | 11.1% |
| Shares Change (QoQ) | 0.29% | 0.54% |
| Float | 38,820,100 | 49,173,100 |
| Shares Held by Insiders | 43.4% | 11.6% |
| Shares Held by Institutions | 121.0% | 59.4% |
Taxes
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Income Tax | $18.40M | $91.50K |
Scores
| Measure | QuidelOrtho | Industry median |
|---|---|---|
| Altman Z-Score | -0.08 | -0.24 |
| Piotroski F-Score | 6 | 4 |
| Beneish M-Score | -3.17 | -2.62 |
Calculated by StockData from QuidelOrtho's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.